There is two legal case on foot in NSW..basically challenging the Biohealth deal and the diverting of proposed acquisition funds to HK companies linked to directors..IMHO if the DFM directors were in Aust they would be headed for fraud charges.
DFM Price at posting:
83.0¢ Sentiment: Hold Disclosure: Held